- Nachrichtendetail
-
24.04.2024 03:34:32 - dpa-AFX: *HANMI, MERCK TO EVALUATE 'BH3120'- KEYTRUDA IN PHASE 1 TRIAL IN PROGRESSIVE OR METASTATIC SOLID TUMOR
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 129,550 | 08.05.24 22:00:05 | -0,830 | -0,64% | 129,420 | 129,550 | 130,580 | 130,380 |
